.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
UBS
Mallinckrodt
Boehringer Ingelheim
Cantor Fitzgerald
Healthtrust
Fuji
Baxter
Citi
Julphar

Generated: July 28, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Phosphinylalkanoyl substituted prolines
Abstract:Esters of phosphinylalkanoyl prolines and phosphinylalkanoyl substituted prolines are inhibitors of angiotensin converting enzyme and are useful in the treatment of hypertension.
Inventor(s): Petrillo, Jr.; Edward W. (Pennington, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:06/326,082
Patent Claims: 1. A compound having the formula ##STR27## or a non-toxic, physiologically acceptable salt thereof, wherein R.sub.1 is alkyl, aryl, arylalkyl, cycloalkyl, or cylcoalkylalkyl;

R.sub.2 and R.sub.4 each is independently hydrogen, alkyl or arylalkyl;

R.sub.3 is hydrogen or alkyl;

--R.sub.5 --COOR.sub.4 is ##STR28## R.sub.6 is cycloalkyl or aryl; R.sub.7 and R'.sub.7 together are --S--(CH.sub.2).sub.2 --S--; and

n is 0 or 1;

and wherein the term "aryl" refers to phenyl or phenyl substituted with halogen, alkyl, alkoxy, alkylthio, hydroxy, alkanoyl, nitro, amino, dialkylamino, or trifluoromethyl groups; the term "alkyl" refers to groups having 1 to 10 carbon atoms; the term "alkoxy" refers to groups having 1 to 8 carbon atoms; the term "cycloalkyl" refers to groups having 3 to 7 carbon atoms; and the term "alkanoyl" refers to groups having 2 to 9 carbon atoms.

2. A compound in accordance with claim 1 wherein n is 0.

3. A compound in accordance with claim 1 wherein each of R.sub.2 and R.sub.4 is hydrogen.

4. A compound in accordance with claim 1 wherein --R.sub.5 --COOR.sub.4 is ##STR29##

5. A compound in accordance with claim 1 wherein --R.sub.5 --COOR.sub.4 is ##STR30##

6. The compound in accordance with claim 1, (S)-7-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-1,4-dithia-7-azaspiro[4.4 ]nonane-8-carboxylic acid, or a physiologically acceptable salt thereof.

7. The compound in accordance with claim 1, (cis)-4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline, or a physiologically acceptable salt thereof.

8. The compound in accordance with claim 1, (cis)-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-4-phenyl-L-proline, or a physiologically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Department of Justice
Merck
Medtronic
Cantor Fitzgerald
Farmers Insurance
Daiichi Sankyo
Queensland Health
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot